REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 21st, 2004 • Cephalon Inc • Pharmaceutical preparations • New York
Cephalon, Inc., a Delaware corporation (the “Company”) proposes to offer to holders (the “Holders”) of its outstanding $375,000,000 of Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2008 and its outstanding $375,000,000 of Zero Coupon Convertible Subordinated Notes due June 15, 2033, First Putable June 15, 2010 (collectively, the “Existing Securities”) to exchange in an exchange offer (the “Exchange Offer”) new securities (the “New Securities”) for any and all of its Existing Securities. The New Securities will be convertible into shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”) at the conversion price set forth in the Offer to Exchange dated November 16, 2004 (the “Offer to Exchange”). The New Securities will be issued pursuant to an Indenture, dated as of December 20, 2004 (the “Indenture”), among the Company and U.S. Bank National Association, as trustee (the “Trustee”). The Company hereby agrees for the ben
